WEST PHARMACEUTICAL SERVICES INC【WST】Cash flow
Market cap
$19.8B
P/E ratio
| 2010/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 8 | 16 | 21 | 19 | 30 | 20 | 16 | 15 | 24 | 34 | 38 | 24 | 23 | 19 |
| Cash from operations | 138 | 187 | 221 | 183 | 212 | 219 | 263 | 289 | 367 | 473 | 584 | 724 | 777 | 653 |
| Capital expenditures | -71 | -131 | -152 | -112 | -132 | -170 | -131 | -105 | -126 | -174 | -253 | -285 | -362 | -377 |
| Cash from investing | -74 | -116 | -150 | -104 | -129 | -176 | -134 | -101 | -228 | -179 | -253 | -288 | -369 | -379 |
| Repurchases of common stock | 2 | 5 | - | - | - | 52 | 74 | 71 | 83 | 116 | 137 | 203 | 438 | 561 |
| Proceeds from issuance of term debt, net | - | 168 | 43 | - | - | - | - | - | - | - | - | - | - | - |
| Repayments of term debt | - | - | - | - | - | - | - | - | 0 | - | - | 1 | - | 169 |
| Cash from financing | -34 | -3 | -5 | -31 | -41 | -114 | -109 | -81 | -37 | -137 | -168 | -294 | -460 | -623 |
| Free cash flow | ||||||||||||||
| FCF margin (%) |